American Association for Cancer Research’s Post

The AACR-AstraZeneca Breast Cancer Fellowship for Endocrine Therapy Research is a two-year, $130,000 grant to support postdoctoral or clinical research fellows conducting breast cancer research. Projects are restricted to basic, clinical, translational, or epidemiological research that substantially advances the field of endocrine therapy in breast cancer. Apply by August 15: https://bit.ly/45OgSQQ

Metabolism and Pancreatic Cancer: Alec C. Kimmelman, Nada Kaalany, Costas A. Lyssiotis, and Kamiya Mehla will address this topic in a plenary session at the AACR Special Conference on Advances in Pancreatic Cancer Research (September 15-18, Boston). Learn more: https://bit.ly/3xFJijk #AACRpan24

Extended Access: Session recordings from the AACR Annual Meeting 2024 are now available to meeting registrants for on-demand viewing through Tuesday, September 3. Registration is open through July 10 for new users who wish to purchase access to these recordings. Learn more: https://bit.ly/4bpM5Lu #AACR24

Patients with solid tumors who received waivers to participate in a large clinical trial had similar outcomes and side effects as patients who met all eligibility criteria, a finding that may support the loosening of clinical trial eligibility requirements. The results of a recent study were published in the AACR journal Clinical Cancer Research. Learn more: https://bit.ly/4cANPCI AACR Journals

The June edition of Editors’ Picks from the 10 AACR journals includes a trial that clinched a new FDA approval for the KRAS inhibitor adagrasib, a new imaging modality to predict glioblastoma response, and a first disclosure of a drug that can boost the effects of multiple treatment types. Learn more on the #AACRBlog: https://bit.ly/3XKT8eg AACR Journals

KYW Newsradio discussed the latest #CancerDisparitiesReport with AACR Chief Philanthropic Officer Mitch Stoller and Steering Committee Member Dr. Camille Ragin of Fox Chase Cancer Center. Listen here: https://bit.ly/4cIHRPQ

The AACR-Novocure Cancer Research Grants provide $350,000 over three years to support independent investigators who are currently conducting innovative research focused on Tumor Treating Fields. Application deadline: July 1. Learn more: https://bit.ly/4eNm4Ze

The AACR Scientific Achievement Awards Program recognizes scientific excellence across the full spectrum of cancer research by honoring scientists, clinicians, and physician-scientists who have made significant contributions to our understanding of the diagnosis, prevention, and treatment of cancer. Nominate a colleague by September 15: https://bit.ly/4eWz7rF

Immunotherapies use, modify, or enhance a patient’s immune system to treat cancer. Learn about the different types of immunotherapies on the #AACRBlog: https://bit.ly/3xDHA1W #CancerImmunotherapyMonth

The AACR-Novocure Career Development Awards for Cancer Research provide $300,000 over three years to early-career investigators who are conducting innovative research focused on Tumor Treating Fields. Apply by July 1. Learn more: https://bit.ly/3XOwqSR